Ara
Toplam kayıt 2, listelenen: 1-2
Outcomes of the novolimus-eluting bioresorbable vascular scaffold in real world clinical practice
(Edizioni Minerva Medica, 2021)
BACKGROUND: Most of the current data regarding the use of bioresorbable scaffolds (BRS) come from everolimus-eluting stent platforms. Adverse events with the everolimus-eluting BRSs which are the most comprehensively ...
Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds in real world patients
(Termedia Publishing House Ltd., 2020)
Introduction: Elevated risk of adverse events in comparison to metallic stents resulted in withdrawal of everolimus-eluting bioresorbable scaffolds (eBVS), known as the most intensively studied BVS. There is a paucity of ...